CELESTE STEVENS: Open Payments
NPI 1346882305 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 36 payments from 15 companies in 2025. Trend: 2023 $663 · 2024 $868 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $161 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Merck Sharp & Dohme LLC | 5 | $89 |
| Novo Nordisk Inc | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Esperion Therapeutics, Inc. | 1 | $27 |
| Boston Scientific Corporation | 1 | $19 |
Products named: REPATHA, VERQUVO, Wegovy, DUPIXENT, SHINGRIX, WAINUA, LEQVIO, NEXLETOL.
Industry payments across NC — which companies pay providers there.
